Anastasya Alexandrovna Goncharova

Ms. Anastasya Alexandrovna Goncharova

Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Science, Tomsk, Tomskaya Oblast’, Russia
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ABAnastasiia Sergeevna Boiko
Anastasiia Sergeevna Boiko
IMIrina Mednova
Irina Mednova
EKElena Kornetova
Elena Kornetova
AGAnastasya Alexandrovna Goncharova
Anastasya Alexandrovna Goncharova
ASArkadiy Semke
Arkadiy Semke
SISvetlana Ivanova
Svetlana Ivanova
Metabolic syndrome (MetS) is a common complication of schizophrenia that is quite exacerbated by long-term use of (atypical) antipsychotics. The mechanism of MetS has neuronal, neuroendocrine, and neuroimmunological components and shows some overlap with those of aspects of schizophrenia. We examined 195 patients with schizophrenia (90 with and 105 without MetS) for the association of serum levels of ghrelin, insulin, and leptin with metabolic abnormalities. Serum glucose levels and lipid profiles were routinely measured with colorimetric enzymatic methods and hormone levels with multiplex analyzers. Leptin levels were highly significantly increased (p < 0.001) in people with MetS (9.966 [5.882; 21.496] vs. 6.35 [2.005; 11.753], Me [Q1; Q3]) and ghrelin levels were actually significantly decreased (p = 0.045). Insulin levels did not differ significantly between those with and without MetS (p = 0.162). In Spearman’s correlation analysis between the hormone levels, body characteristics, and biochemical parameters, significant correlations were seen somewhat more often in people without MetS than in those with MetS and also less often for ghrelin than for the other hormones. We conclude that evidence exists for a role in the development of MetS especially for leptin, but that less is supporting a role for ghrelin.

23 July 2022 in Genes
Verified
Journal Article
Open access
PDF file
DPDiana Paderina
Diana Paderina
ABAnastasiia Sergeevna Boiko
Anastasiia Sergeevna Boiko
IPIvan Pozhidaev
Ivan Pozhidaev
IMIrina Mednova
Irina Mednova
AGAnastasya Alexandrovna Goncharova
Anastasya Alexandrovna Goncharova
SISvetlana Ivanova
Svetlana Ivanova
Background: Metabolic syndrome is widespread in patients with schizophrenia receiving long-term antipsychotic therapy. Dopamine D2 receptors play an important role in mediating both the therapeutic actions of antipsychotics and their side effects. The present study examined the association of two polymorphisms of the DRD2 gene with metabolic syndrome in patients with schizophrenia. Methods: We examined 517 patients from several regions of Siberia (Russia) with a clinical diagnosis of schizophrenia. Genotyping of two single nucleotide polymorphisms rs1799732 and rs4436578 of the dopamine D2 receptor gene (DRD2) was performed in a population of 471 patients. The results were analyzed using chi-square tests. Results: Functional polymorphism rs1799732 of the DRD2 gene is associated with drug-induced metabolic syndrome in women with schizophrenia. Conclusions: Our results show that the DRD2 gene may be involved in the pathogenesis of metabolic disorders in patients with schizophrenia. Further analysis of possible genetic markers will allow for personalized treatment with minimal side effects and optimal efficacy. This which seems relevant in light of the recent focus on improving the quality of life and ensuring a high level of social adaptation of patients with schizophrenia.

8 May 2022 in Genes
Verified
Journal Article
Open access
PDF file
ABAnastasiia Sergeevna Boiko
Anastasiia Sergeevna Boiko
IPIvan Pozhidaev
Ivan Pozhidaev
DPDiana Paderina
Diana Paderina
IMIrina Mednova
Irina Mednova
AGAnastasya Alexandrovna Goncharova
Anastasya Alexandrovna Goncharova
SISvetlana Ivanova
Svetlana Ivanova
Background: Metabolic syndrome (MetS) is a common complication of long-term treatment of persons with schizophrenia taking (atypical) antipsychotics. In this study, we investigated the existence of an association with polymorphisms of genes for four hormones that regulate energy metabolism. Methods: We recruited 517 clinically admitted white patients (269M/248F) with a verified diagnosis of schizophrenia (ICD-10) and with a stable physical condition. Participants were classified for having or not having MetS and genotyped for 20 single-nucleotide polymorphisms (SNPs) in the genes encoding insulin-induced gene 2 (INSIG2), ghrelin (GHRL), leptin (LEP), and leptin receptor (LEPR). Results: The 139 patients (26.9%) with MetS were significantly more likely to be women, older, and ill longer, and had a larger body mass index (BMI). Four polymorphisms (rs10490624, rs17587100, rs9308762, and rs10490816) did not meet the Hardy–Weinberg equilibrium (HWE) criterion and were excluded. Only genotypes and alleles of the rs3828942 of LEP gene (chi2 = 7.665, p = 0.022; chi2 = 5.136, p = 0.023) and the genotypes of the rs17047718 of INSIG2 gene (chi2 = 7.7, p = 0.021) had a significant association with MetS. Conclusions: The results of our study suggest that the LEP and INSIG2 genes play a certain causal role in the development of MetS in patients with schizophrenia.

1 January 2021 in Sibirskiy psikhologicheskiy zhurnal
Verified
Journal Article
Closed access
SUSiberian State Medical University
Siberian State Medical University
AKAlexander Kornetov
Alexander Kornetov
KYKonstantin G. Yazykov
Konstantin G. Yazykov
EKElena G. Kornetova
Elena G. Kornetova
OFOlga Fedorenko
Olga Fedorenko
NBNikolay A. Bokhan
Nikolay A. Bokhan
The article provides arguments in favor of developing ideas about cognitive functions and their implementation not only in the practice of scientific knowledge, but also in everyday life. The relevance of the study is due to the priority links with psychosocial functions and cognitive management of public life. The aim of the study was to provide a normative assessment of cognitive functions using the Brief Assessment of Cognitive Functions in Patients with Schizophrenia (BACS) scale in the Tomsk population of healthy individuals. Our objectives were to determine the nature and severity of cognitive functions in the representation of the BACS scale in a group of healthy individuals in the study of the normative indicators variability in different populations; to determine the influence of constitutional factors (gender, age) on the variability of cognitive functions (CF) indicators; to carry out a comparative analysis with the data obtained from other normative indicators studies; to determine the variability of CF indicators in the covariance-dispersion representation; to determine the co-variability of CF indicators in the covariance-dispersion representation. The sample consisted of 161 people without mental disorders living in Tomsk. The age ranged from 20 to 69 years old. The markers of the state of cognitive functions are the assessments of the BACS scale. The BACS scale meets the requirements for rapid assessment of the cognitive functions state and includes tasks for evaluation of planning and control functions, speech fluency, working memory, and motor skills. This study keeps developing ideas about cognitive indicators of the Russian population norm. The article examines the gender and age influence on the scale assessments. Statistically significant decrease with age in male and female subpopulations for all tests is shown. The most significant decrease is noted for test scores “Symbol Coding” and “Tower of London”. Comparative analysis of the state of cognitive functions shows that in the Tomsk population “Token Motor" and "Verbal Fluency" indicators were higher and other test indicators were significantly lower than those of the Moscow sample. The variability of the scale values is found to be due to such constitutional factors as age and gender. According to ANOVA data, gender and age significantly influences the mean scores of test performance. Based on the calculations of the covariance-dispersion matrix, it is shown that cognitive functions are highly connected in the male subpopulation. Comparison of empirical data from different study groups shows that the BACS reveals high validity with respect to measurable attributes and sensitivity to regional variability in CF indices. The scores can be used as normative for the Tomsk population when studying neu-rocognitive deficits in patients with schizophrenia.

22 June 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
OFOlga Fedorenko
Olga Fedorenko
DPDiana Paderina
Diana Paderina
EKElena Kornetova
Elena Kornetova
EPEvgeniya Poltavskaya
Evgeniya Poltavskaya
IPIvan Pozhidaev
Ivan Pozhidaev
SISvetlana Ivanova
Svetlana Ivanova
Background: Tardive dyskinesia (TD) is an extrapyramidal side effect of the long-term use of antipsychotics. In the present study, the role of glutamatergic system genes in the pathogenesis of total TD, as well as two phenotypic forms, orofacial TD and limb-truncal TD, was studied. Methods: A set of 46 SNPs of the glutamatergic system genes (GRIN2A, GRIN2B, GRIK4, GRM3, GRM7, GRM8, SLC1A2, SLC1A3, SLC17A7) was studied in a population of 704 Caucasian patients with schizophrenia. Genotyping was performed using the MassARRAY Analyzer 4 (Agena Bioscience™). Logistic regression analysis was performed to test for the association of TD with the SNPs while adjusting for confounders. Results: No statistically significant associations between the SNPs and TD were found after adjusting for multiple testing. Since three SNPs of the SLC1A2 gene demonstrated nominally significant associations, we carried out a haplotype analysis for these SNPs. This analysis identified a risk haplotype for TD comprising CAT alleles of the SLC1A2 gene SNPs rs1042113, rs10768121, and rs12361171. Nominally significant associations were identified for SLC1A3 rs2229894 and orofacial TD, as well as for GRIN2A rs7192557 and limb-truncal TD. Conclusions: Genes encoding for mGlu3, EAAT2, and EAAT1 may be involved in the development of TD in schizophrenia patients.

19 April 2023 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
EKElena Kornetova
Elena Kornetova
AGAnastasya Alexandrovna Goncharova
Anastasya Alexandrovna Goncharova
IMIrina Mednova
Irina Mednova
AKAlexander Kornetov
Alexander Kornetov
TSTatiana Saprina
Tatiana Saprina
ASArkadiy Semke
Arkadiy Semke
Objective: identify differences or comparability of constitutional-morphological characteristics and indicators of the fatty constitution between patients with schizophrenia and people with MetS and without mental disorders.Materials and methods. We examined 63 patients with schizophrenia and MetS (25 women, 38 men), aged 30 [33;52], and 50 mentally healthy individuals with MetS (28 women, 22 men) aged 57 [49; 60]. The main criterion for inclusion in the study was the presence of a verified MetS according to the criteria of the International Diabetes Federation. Anthropometric examination was performed according to the method of V.V. Bunak (1941) with the underlying calculation of integral indices. The determination of the fat component included: measuring waist circumference; non-invasive bioimpedancemetry – body weight, BMI, total and visceral fat content; determination of the total fat fold (electronic caliper). In the blood serum, the concentration of glucose, total cholesterol, HDL, TG was determined using standard commercial kits, the calculation of LDL and the Atherogenic Index.Results. Differences in the prevalence of the constitutional-morphological type and the type of somatic sexual differentiation were not established in the groups. The level of visceral fat and BMI were higher in mentally healthy individuals with MetS than in schizophrenic patients with MetS (p = 0.005 and p = 0.0001, respectively). Patients with schizophrenia and MetS had low serum glucose levels compared with individuals without mental disorders (p = 0.0001). An increase in the level of TG and the Atherogenic Index was found in patients with schizophrenia with MetS (p = 0.026 and p = 0.03, respectively), and the level of HDL was reduced (p = 0.022).Conclusion. The constitutional and morphological basis of MetS in patients with schizophrenia and persons without mental disorders is the same, however, changes in the fat constitution were determined for mentally healthy individuals. Changes in the lipid profile and glucose concentration may be associated with the presence of MetS-specific risk factors for patients with schizophrenia.